Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.25%41.41B | 1.84%9.9B | -3.97%10.27B | 0.02%41.31B | 2.43%11.51B | -3.22%9.38B | 1.49%9.72B | -0.87%10.7B | 0.14%41.3B | 0.39%11.24B |
| Cost of revenue | -0.57%24.29B | 1.17%5.83B | -4.79%5.89B | 0.27%24.43B | -1.81%6.85B | -2.85%5.63B | 3.86%5.76B | 2.36%6.19B | 4.38%24.37B | 7.07%6.97B |
| Gross profit | 1.42%17.11B | 2.83%4.07B | -2.85%4.38B | -0.33%16.87B | 9.34%4.67B | -3.78%3.74B | -1.78%3.95B | -4.99%4.51B | -5.38%16.93B | -8.90%4.27B |
| Operating expense | -0.58%12.75B | -1.71%3.27B | -0.17%3B | -2.14%12.83B | -3.35%3.37B | -2.69%3.12B | 0.53%3.33B | -3.07%3B | -1.70%13.11B | 2.51%3.49B |
| Staff costs | 2.74%6.02B | ---- | ---- | 1.43%5.86B | ---- | ---- | ---- | ---- | -0.47%5.78B | ---- |
| Selling and administrative expenses | -6.17%2.62B | ---- | ---- | -9.13%2.8B | ---- | ---- | ---- | ---- | -5.89%3.08B | ---- |
| -Selling and marketing expense | -6.17%2.62B | ---- | ---- | -9.13%2.8B | ---- | ---- | ---- | ---- | -5.89%3.08B | ---- |
| Depreciation and amortization | -31.40%161.05M | ---- | ---- | 2.59%234.77M | ---- | ---- | ---- | ---- | -0.10%228.85M | ---- |
| -Depreciation | -31.40%161.05M | ---- | ---- | 2.59%234.77M | ---- | ---- | ---- | ---- | -0.10%228.85M | ---- |
| Other operating expenses | 0.29%3.94B | ---- | ---- | -2.19%3.93B | ---- | ---- | ---- | ---- | -0.17%4.02B | ---- |
| Operating profit | 7.78%4.36B | 27.00%794.52M | -8.19%1.38B | 5.86%4.05B | 66.35%1.29B | -8.90%623.5M | -12.50%625.61M | -8.60%1.5B | -16.13%3.82B | -39.25%777.36M |
| Net non-operating interest income (expenses) | 42.99%4.84M | 2.00%815K | -4.66%798K | 26.85%3.39M | -4.95%768K | -7.35%983K | 14.96%799K | 689.62%837K | 140.32%2.67M | 199.26%808K |
| Non-operating interest income | 54.04%5.23M | 2.00%816K | -4.65%799K | 26.76%3.39M | -5.06%769K | -7.34%985K | 14.94%800K | 683.18%838K | 139.78%2.68M | 197.79%810K |
| Non-operating interest expense | 7,540.00%382K | 0.00%1K | 0.00%1K | -16.67%5K | -50.00%1K | 0.00%2K | 0.00%1K | 0.00%1K | 20.00%6K | 0.00%2K |
| Net investment income | 8.35%137.12M | 5.69%53.07M | 81.71%17.14M | 17.11%126.56M | 155.04%65.55M | -64.06%1.37M | -18.19%50.21M | -45.07%9.43M | -5.02%108.07M | -52.15%25.7M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 739.23%241.81M | -54.40%28.81M | 1,795,100.00%17.95M | 4.61M | 97.01%63.19M | -99.99%1K | ||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -562.08%-284.34M | 227.34%666K | -96.67%3.6M | 284.43%61.54M | -689.45%-44.7M | -121.39%-1.57M | 98.92%-523K | 108.33M | 79.35%-33.37M | 410.78%7.58M |
| Less:Other special charges | 96.68%-2.04M | -227.34%-666K | 96.67%-3.6M | -284.43%-61.54M | 689.45%44.7M | 121.39%1.57M | --523K | ---108.33M | -78.81%33.37M | -350.30%-7.58M |
| Less:Write off | --286.38M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -269.11%-127.16M | 4.06%23.85M | -29.22%12.06M | 17.08%75.19M | -58.20%6.04M | 25.11%29.2M | 113.74%22.92M | 8.36%17.03M | 639.49%64.22M | 214.67%14.44M |
| Income before tax | -0.19%4.33B | 37.12%967.05M | -13.73%1.41B | 7.81%4.34B | 62.09%1.34B | -8.60%658.1M | -11.31%705.27M | -2.75%1.64B | -11.12%4.03B | -38.04%825.89M |
| Income tax | -0.09%1.47B | 34.84%329.24M | -13.98%468.25M | 9.08%1.47B | 68.04%451.14M | -7.07%230.06M | -12.98%244.17M | -1.15%544.35M | -10.27%1.35B | -38.40%268.47M |
| Net income | -0.25%2.87B | 38.32%637.81M | -13.61%946.54M | 7.17%2.87B | 59.23%887.58M | -9.40%428.04M | -10.39%461.1M | -3.52%1.1B | -11.54%2.68B | -37.87%557.42M |
| Net income continuous operations | -0.25%2.87B | 38.33%637.81M | -13.61%946.54M | 7.17%2.87B | 59.23%887.58M | -9.40%428.04M | -10.39%461.1M | -3.52%1.1B | -11.54%2.68B | -37.87%557.42M |
| Noncontrolling interests | -61.68%62.76M | 4.50%40.25M | -88.19%4.25M | 2.57%163.77M | 99.17%84.83M | -75.58%4.45M | 15.35%38.51M | -45.05%35.98M | -1.18%159.67M | -20.33%42.59M |
| Net income attributable to the company | 3.46%2.8B | 41.41%597.56M | -11.07%942.29M | 7.47%2.71B | 55.92%802.75M | -6.74%423.59M | -12.18%422.58M | -0.98%1.06B | -12.12%2.52B | -38.98%514.83M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 3.46%2.8B | 41.41%597.56M | -11.07%942.29M | 7.47%2.71B | 55.92%802.75M | -6.74%423.59M | -12.18%422.58M | -0.98%1.06B | -12.12%2.52B | -38.98%514.83M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 3.79%148.63 | 44.70%32.37 | -8.29%50.91 | 10.37%143.2 | 60.69%42.84 | -3.73%22.48 | -9.54%22.37 | 0.93%55.51 | -11.98%129.74 | -38.51%26.66 |
| Diluted earnings per share | 3.79%148.63 | 45.19%32.3659 | -8.29%50.91 | 10.37%143.2 | 60.69%42.84 | -3.71%22.48 | -9.86%22.2926 | 0.93%55.51 | -11.98%129.74 | -38.51%26.66 |
| Dividend per share | 27.78%46 | 16.67%14 | 0 | 16.13%36 | 14.29%24 | 0 | 20.00%12 | 0 | 3.33%31 | 5.00%21 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |